Moskva, Moscow, Russian Federation
Moskva, Moscow, Russian Federation
Moskva, Moscow, Russian Federation
The article presents the results of clinical studies of the effectiveness of artificial pneumothorax in the treatment of 124patients with cavernous pulmonary tuberculosis patients and extensively drug resistance. Clinical trials of the use of artificial pneumothorax in young patients with cavernous pulmonary tuberculosis MDR and XDR MBT have proved its high efficiency and that it can be recommended for widespread clinical use. The indications for the use of artificial pneumothorax is a cavernous pulmonary tuberculosis with the release of MDR and XDR MBT with unformed or formed thin-walled cavity not larger than 4 cm in diameter. Pleuropulmonary adhesions revealed at primary application of artificial pneumothorax are the direct indications fpr surgical burn of adhesions. With the diameter of cavities up to 2cm the artificial pneumothorax treatment is applied for 6months and with cavities of 2–4cm in diameter – for 12months. Contraindications to the use of artificial pneumothorax are cavities in the lungs more than 4cm in diam-eter, massive pleural commissures, with the impossibility of their surgical burnout; specific lesion bronchial tubes and severe comorbidities (mental illness, organic lesions of the central nervous system, chronic obstructive lung disease, chronic cardiovascular diseases in the stage of decompensation, congenital malformations of the heart and lungs, chest wall deformity). Treatment of patients with artificial pneumothorax cavernous pulmonary tuberculosis MDR and XDR pathogen can be recommended for use in stationary phase in TB facilities with thoracic surgery, where the implementation of operational burnout pleural commissures is possible.
pulmonary tuberculosis, drug-resistant Mycobacterium tuberculosis, artificial pneumothorax
1. GordinaAV, ZaychenkoNM, KucheryavayaDA,NechaevaOB, SonIM (2015). Resources and activity of anti-TB institutions of the Russian Federation in 2013-2014. (statistical materials) [Resursy i deyatel’nost’ protivotuberkuleznykh organizatsiy Rossiyskoy Federatsii v 2013-2014 gg. (statisticheskie materialy)], 89.
2. MishinVY, ChukanovVI, OsadchayaOA (2008). Ef-fectiveness of artificial pneumothorax in complex treat-ment of patients with destructive pulmonary tuberculosis with multidrug-resistant Mycobacterium in the pri-mary and secondary drugs [Effektivnost’ iskusstvennogo pnevmotoraksa v kompleksnom lechenii bol’nykh destruktivnym tuberkulezom legkikh s mnozhestvennoy lekarstvennoy ustoychivost’yu mikobakteriy k osnovnym i rezervnym preparatam]. Nauchnye trudy Vserossiyskoy nauchno-prakticheskoy konferentsii, 58-63.
3. MishinVY, KomissarovaOG, ChukanovVI, KononetsBY(2009). Peculiarities of the process and the effectiveness of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis and extensively drug-resistant TB drugs [Osobennosti techeniya protsessa i effektivnost’ lecheniya bol’nykh tuberkulezom legkikh, vydelyayushchikh mikobakterii tuberkuleza s shirokoy lekarstvennoy ustoychivost’yu k protivotuberkuleznym preparatam]. Problemy tuberkuleza i bolezni legkikh, (2), 50-52.
4. MishinVY (2007). Pulmonary tuberculosis with drug-resistant of the pathogen [Tuberkulez legkikh s lekarstvennoy ustoychivost’yu vozbuditelya], 197.
5. MishinVY, KononetsAS, MyakishevaNE, Khoroshilo-vaNE (2011) Comparative efficacy of chemotherapy of pulmonary tuberculosis with multidrug-resistant pathogen from the standpoint of medical of evidence [Sravnitel’naya effektivnost’ khimioterapii tuberkuleza legkikh s mnozhestvennoy lekarstvennoy ustoychivost’yu vozbuditelya s pozitsiy meditsiny dokazatel’stv] Bulleten’ Vostocno-Sibirskogo naucnogo centra, (2), 246-248.
6. MishinaAV, AndrianovaAY, LuzinaNV, Osintse-vaIY, MishinVY (2011). The effectiveness of artificial pneumothorax in complex treatment of patients with destructive pulmonary tuberculosis with different char-acter of drug sensitivity of the pathogen [Effektivnost’ iskusstvennogo pnevmotoraksa v kompleksnom lechenii bol’nykh destruktivnym tuberkulezom legkikh s razlichnym kharakterom lekarstvennoy chuvstvitel’nosti vozbuditelya]. Meditsina kriticheskikh sostoyaniy, (1-2), 3-9.
7. MikhaylovFA (1952). Theory and practice of therapeutic pneumothorax [Teoriya i praktika lechebnogo pnevmotoraksa], 52.
8. OsadchayaOA, MishinVY, ChukanovVI (2010). Artificial pneumothorax in the treatment of destruc-tive pulmonary tuberculosis with different character of drug sensitivity of the pathogen [Iskusstvennyy pnevmotoraks v lechenii destruktivnogo tuberkuleza legkikh s razlichnym kharakterom lekarstvennoy chuvstvitel’nosti vozbuditelya]. Nauchnye trudy k 85-letiyu M.M. Averbakha Moskovskogo NPTs bor’by s tuberkulezom, 283-287.
9. RabukhinAE (1970). The chemotherapy of pulmo-nary tuberculosis patients [Khimioterapiya bol’nykh tuberkulezom legkikh], 400.
10. Federal guidelines on the use of drugs (formulary system). Section18.2.13. Antituberculosis drugs (2016) [Federal’noe rukovodstvo po ispol’zovaniyu lekarstvennykh preparatov (formulyarnaya sistema). Razdel 18.2.13. Protivotuberkuleznye preparaty], 699-706.
11. PerelmanMI (ed.) (2007). Phthisiatry. National guidelines [Ftiziatriya. Natsional’noe rukovodstvo], 506.
12. ChukanovVI, MishinVY, GillerDB, OsadchayaOA,BizhanovAB (2013). Artificial pneumothorax and combination chemotherapy in treatment of patients with destructive pulmonary tuberculosis with the different nature of drug resistance [Iskusstvennyy pnevmotoraks i kombinirovannaya khimioterapiya v kompleksnom lechenii bol’nykh destruktivnym tuberkulezom legkikh s razlichnym kharakterom lekarstvennoy ustoychivosti vozbuditelya]. Tuberkulez i bolezni legkikh, 90(2), 48-57.
13. ShebanovFV (1950). Collapse therapy of pulmonary tuberculosis [Kollapsoterapiya legochnogo tuberkuleza], 107
14. ShilovaMV (2015). Tuberculosis in Russia in 2014 [Tuberkulez v Rossii v 2014 godu], 236.
15. EynisVL (1945). Collapse therapy in pulmonary tuberculosis [Kollapsoterapiya pri tuberkuleze legkikh]. Problemy tuberkuleza, (2), 12-14
